BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11310354)

  • 1. Improving the physical health of patients with schizophrenia: therapeutic nihilism or realism?
    Le Fevre PD
    Scott Med J; 2001 Feb; 46(1):11-3. PubMed ID: 11310354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor physical health and mortality in patients with schizophrenia.
    Pack S
    Nurs Stand; 2009 Jan 28-Feb 3; 23(21):41-5. PubMed ID: 19248449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism, lifestyle and bipolar affective disorder.
    Morriss R; Mohammed FA
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):94-101. PubMed ID: 16280342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in schizophrenia.
    Auquier P; Lançon C; Rouillon F; Lader M
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1308-12. PubMed ID: 17944000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Schizophrenia--a life shortening disease].
    Munitz H
    Harefuah; 2010 Aug; 149(8):508-11, 551. PubMed ID: 21341429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life expectancy and cardiovascular mortality in persons with schizophrenia.
    Laursen TM; Munk-Olsen T; Vestergaard M
    Curr Opin Psychiatry; 2012 Mar; 25(2):83-8. PubMed ID: 22249081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet, smoking and cardiovascular risk in schizophrenia in high and low care supported housing.
    Gupta A; Craig TK
    Epidemiol Psichiatr Soc; 2009; 18(3):200-7. PubMed ID: 20034197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications.
    Beary M; Hodgson R; Wildgust HJ
    J Psychopharmacol; 2012 May; 26(5 Suppl):52-61. PubMed ID: 22465947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.
    Van Gaal LF
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S142-8. PubMed ID: 16863690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The issue of mortality in schizophrenia].
    Corruble E
    Therapie; 2008; 63(3):247-50. PubMed ID: 18718214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and physical health problems.
    von Hausswolff-Juhlin Y; Bjartveit M; Lindström E; Jones P
    Acta Psychiatr Scand Suppl; 2009; (438):15-21. PubMed ID: 19132962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical health of patients with severe mental illness: an intervention on medium secure forensic unit.
    Vasudev K; Thakkar PB; Mitcheson N
    Int J Health Care Qual Assur; 2012; 25(4):363-70. PubMed ID: 22755485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia and increased risks of cardiovascular disease.
    Hennekens CH; Hennekens AR; Hollar D; Casey DE
    Am Heart J; 2005 Dec; 150(6):1115-21. PubMed ID: 16338246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess early mortality in schizophrenia.
    Laursen TM; Nordentoft M; Mortensen PB
    Annu Rev Clin Psychol; 2014; 10():425-48. PubMed ID: 24313570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lifestyle interventions and weight management in schizophrenia.
    Bushe C; Haddad P; Peveler R; Pendlebury J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of diabetes and cardiovascular disease in people with schizophrenia.
    Holt RI
    Acta Psychiatr Scand; 2015 Aug; 132(2):86-96. PubMed ID: 25976975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in advancing mental and physical health of patients with serious mental illness.
    Dursun S; Dinan TG; Bushe C; Thakore J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):3-5. PubMed ID: 16280332
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
    Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
    J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics: enhancing healthy outcomes.
    Casey DE
    Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S12-9. PubMed ID: 12046020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.